{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:57:10Z","timestamp":1785419830448,"version":"3.56.0"},"reference-count":30,"publisher":"Frontiers Media SA","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2375,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1111\/j.1432-2277.2008.00768.x","type":"journal-article","created":{"date-parts":[[2008,12,2]],"date-time":"2008-12-02T18:31:43Z","timestamp":1228242703000},"page":"279-286","source":"Crossref","is-referenced-by-count":60,"title":["Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function"],"prefix":"10.3389","volume":"22","author":[{"given":"Paolo","family":"De Simone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Carrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Precisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Petruccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidiana","family":"Baldoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Balzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Ducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Caneschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Coletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Campani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Filipponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","reference":[{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199410273311711","article-title":"Immunosuppression in liver transplantation","volume":"331","author":"Calne","year":"1994","journal-title":"NEJM"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.semnephrol.2007.03.010","article-title":"Renal disease in recipients of nonrenal solid organ transplantation","volume":"27","author":"Ojo","year":"2007","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2000.tb01004.x","article-title":"Neurotoxicity of calcineurin inhibitors: impact and clinical management","volume":"13","author":"Bechstein","year":"2000","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/01.tp.0000262706.28513.6a","article-title":"Reducing the risk of cardiovascular disease in liver allograft recipients","volume":"83","author":"Mells","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/lt.20439","article-title":"New-onset diabetes mellitus after liver transplantation: from pathogenesis to management","volume":"11","author":"Marchetti","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1432-2277.2007.00528.x","article-title":"Calcineurin-inhibitor free immunosuppression in kidney transplantation","volume":"20","author":"Guerra","year":"2005","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2006-947290","article-title":"Immunosuppression: today, tomorrow, and withdrawal","volume":"26","author":"Hirose","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00007890-200001270-00019","article-title":"Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation","volume":"69","author":"Hirose","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB9","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.transproceed.2007.09.008","article-title":"Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy","volume":"39","author":"Chapman","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-199707150-00007","article-title":"SDZ RAD, a new rapamycin derivative: synergism with cyclosporine","volume":"64","author":"Schuurman","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1053-2498(98)00020-5","article-title":"Suppression of acute rejection in allogenic rat transplantation: a study of the efficacy and pharmacokinetics of rapamycine derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyslosporine","volume":"18","author":"Hausen","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00007890-200101150-00028","article-title":"Pharmacokinetics and tolerability of 40-0[2-hydroxyethyl]rapamycin in de novo liver transplant recipients","volume":"71","author":"Levy","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB13","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/lt.20707","article-title":"Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results","volume":"12","author":"Levy","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ygyno.2005.12.019","article-title":"Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells","volume":"102","author":"Treeck","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB15","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1158\/1078-0432.CCR-06-2770","article-title":"RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model","volume":"13","author":"Mabuchi","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1111\/j.1432-2277.2008.00768.x-BIB16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000111501","article-title":"Octeotride and the mTOR inhibitor RAD001 (Everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell line","volume":"87","author":"Grozinsky-Glasberg","year":"2008","journal-title":"Neuroendocrinology"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB17","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.tp.0000280549.93403.dd","article-title":"Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms","volume":"84","author":"Gomez-Camarero","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/jlts.2000.19023","article-title":"Experience with the use of sirolimus in liver transplantation-use in patients for whom calcineurin inhibitors are contraindicated","volume":"6","author":"Chang","year":"2000","journal-title":"Liver Transpl"},{"issue":"Suppl. 7","key":"10.1111\/j.1432-2277.2008.00768.x-BIB19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1399-0012.16.s7.7.x","article-title":"Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent","volume":"16","author":"Cotterell","year":"2002","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1432-2277.2003.tb00339.x","article-title":"Sirolimus and mycophenolate mofetil after liver transplantation","volume":"16","author":"Kniepeiss","year":"2003","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jlts.2003.50026","article-title":"Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients","volume":"9","author":"Nair","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/jlts.2003.50183","article-title":"Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus","volume":"9","author":"Fairbanks","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB23","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/lt.21116","article-title":"Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients","volume":"13","author":"Morard","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB24","first-page":"376","article-title":"Sirolimus as primary immunosuppressant for calcineurin inhibitor-related insufficiency after liver transplantation","volume":"6","author":"Yang","year":"2007","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB25","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.tp.0000261630.63550.41","article-title":"Sirolimus conversion in liver transplant recipient with renal dysfunction: a prospective, randomized, single-center trial","volume":"83","author":"Shenoy","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB26","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/lt.21314","article-title":"A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function","volume":"13","author":"Watson","year":"2007","journal-title":"Liver Transpl"},{"issue":"Suppl. 1","key":"10.1111\/j.1432-2277.2008.00768.x-BIB27","first-page":"113","article-title":"Conversion from calcineurin inhibitors (CNIs) to sirolimus (SRL) immunosuppression is beneficial in liver transplant (LT) recipients with renal dysfunction (RD) [abstract]","volume":"13","author":"Cejas","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockroft","year":"1976","journal-title":"Nephron"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB29","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/ndt\/12.10.2060","article-title":"National Kidney Foundation: Dialysis Outcome Quality Initiative-Development of methodology for practice guidelines","volume":"12","author":"Levin","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00768.x-BIB30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: an international consensus document","volume":"25","author":"Demetris","year":"1997","journal-title":"Hepatology"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2008.00768.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2008.00768.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:38:49Z","timestamp":1641062329000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2008.00768.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00768.x","relation":{},"ISSN":["0934-0874","1432-2277"],"issn-type":[{"value":"0934-0874","type":"print"},{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}